KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Long-Term Debt Repayments (2016 - 2025)

Medtronic's Long-Term Debt Repayments history spans 10 years, with the latest figure at $1.8 billion for Q4 2025.

  • For Q4 2025, Long-Term Debt Repayments changed N/A year-over-year to $1.8 billion; the TTM value through Jan 2026 reached $2.9 billion, changed N/A, while the annual FY2023 figure was $6.0 billion, 601100.0% up from the prior year.
  • Long-Term Debt Repayments for Q4 2025 was $1.8 billion at Medtronic, up from $1.2 billion in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $2.9 billion in Q2 2023 and bottomed at $1.0 million in Q3 2021.
  • The 4-year median for Long-Term Debt Repayments is $1.0 billion (2021), against an average of $1.2 billion.
  • The largest annual shift saw Long-Term Debt Repayments plummeted 90.91% in 2021 before it surged 231000.0% in 2022.
  • A 4-year view of Long-Term Debt Repayments shows it stood at $1.0 million in 2021, then soared by 231000.0% to $2.3 billion in 2022, then rose by 26.74% to $2.9 billion in 2023, then plummeted by 39.64% to $1.8 billion in 2025.
  • Per Business Quant, the three most recent readings for MDT's Long-Term Debt Repayments are $1.8 billion (Q4 2025), $1.2 billion (Q3 2025), and $2.9 billion (Q2 2023).